Sep 11, 2023 / 12:00PM GMT
Terence C. Flynn - Morgan Stanley, Research Division - Equity Analyst
Well, thanks. Good morning, everybody. Thanks for joining us. I'm Terence Flynn, the U.S. biopharma analyst at Morgan Stanley. Very pleased to kick off the conference this morning with Bristol-Myers.
Before we get started, for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, reach out to your Morgan Stanley sales rep.
Joining us today from the company, we have Giovanni Caforio, Chairman and CEO; and Chris Boerner, who is Chief Operating Officer and CEO-Elect, will take over in November. But thank you very much, both, for being here. And congrats, both, on next steps.
Giovanni Caforio - Bristol-Myers Squibb Company - Chairman of the Board & CEO
Thank you.
Christopher S. Boerner - Bristol-Myers Squibb Company - Executive VP, COO & Director
Bristol-Myers Squibb Co at Morgan Stanley Global Healthcare Conference Transcript
Sep 11, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers